ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Characterization of the Immune Cell Infiltration Landscape Uncovers Prognostic and Immunogenic Characteristics in Lung Adenocarcinoma

Wang, Xin; Xu, Zhenyi; Liu, Zhilin; Lin, Weihao; Cao, Zheng; Feng, Xiaoli; Gao, Yibo*; He, Jie*北京大学; 哈尔滨医科大学; 中国医学科学院; 中国医学科学院北京协和医院
Frontiers in Genetics2022-5-23DOI: 10.3389/fgene.2022.902577
2被引4阅读
引用收藏
分享

摘要

The immune cell infiltration in TME has been reported to be associated with prognosis and immunotherapy efficiency of lung cancers. However, to date, the immune infiltrative landscape of lung adenocarcinoma (LUAD) has not been elucidated yet. Therefore, this study aimed to identify a new transcriptomic-based TME classification and develop a risk scoring system to predict the clinical outcomes of patients with LUAD. We applied "CIBERSORT" algorithm to analyze the transcriptomic data of LUAD samples and classified LUAD into four discrete subtypes according to the distinct immune cell infiltration patterns. Furthermore, we established a novel predictive tool (TMEscore) to quantify the immune infiltration patterns for each LUAD patient by principal component analysis. The TMEscore displayed as a reliable and independent prognostic biomarker for LUAD, with worse survival in TMEscrore-high patients and better survival in TMEscrore-low patients in both TCGA and other five GEO cohorts. In addition, enriched pathways and genomic alterations were also analyzed and compared in different TMEscore subgroups, and we observed that high TMEscore was significantly correlated with more aggressive molecular changes, while the low TMEscore subgroup enriched in immune active-related pathways. The TMEscore-low subtype showed overexpression of PD-1, CTLA4, and associations of other markers of sensitivity to immunotherapy, including TMB, immunophenoscore (IPS) analysis, and tumor immune dysfunction and exclusion (TIDE) algorithm. Conclusively, TMEscore is a promising and reliable biomarker to distinguish the prognosis, the molecular and immune characteristics, and the benefit from ICIs treatments in LUAD.

学科与关键词

关键词
immune cell infiltrationprognosislung adenocarcinomatumor microenvironmentimmunotherapy
相关
加载中…
  • The relationship between tumor infiltrating immune cells and the prognosis of patients with lung adenocarcinoma
    Tong, Zhuang; Wang, Xu; Liu, Hongyu; Ding, Jian; Chu, Yinling; Zhou, Xin*Journal of Thoracic Disease, 2023, 15(2): 600-610.
  • LATPS, a novel prognostic signature based on tumor microenvironment of lung adenocarcinoma to better predict survival and immunotherapy response
    Huang, Jihong; Yuan, Lu; Huang, Wenqi; Liao, Liwei; Zhu, Xiaodi; Wang, Xiaoqing; Li, Jiaxin; Liang, Wenyu; Wu, Yuting; Liu, Xiaocheng; Yu, Dong; Zheng, Yunna; Guan, Jian*; Zhan, Yongzhong*; Liu, Laiyu*Frontiers in Immunology, 2022, 13: 1064874.被引 2
  • Characterization of lung adenocarcinoma based on immunophenotyping and constructing an immune scoring model to predict prognosis
    Liu, Mengfeng; Xiao, Qifan; Yu, Xiran; Zhao, Yujie; Qu, Changfa*Frontiers in Pharmacology, 2022, 13: 1081244.
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Genetics
发表日期
2022-05-23
卷期
第 13 卷
页码
902577
DOI
10.3389/fgene.2022.902577
期刊等级
3区
成果收录
SCIE
资助标注
National Key R&D Program of China [2020AAA0109500]; R&D Program of Beijing Municipal Education Commission [KJZD20191002302]; National Natural Science Foundation of China [82122053, 82188102]; Beijing Municipal Science & Technology Commission [Z191100006619115]; CAMS Initiative for Innovative Medicine [2021-I2M-1-012 2021-I2M-1-015]; Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences [2021-PT310-001]; Key-Area Research and Development Program of Guangdong Province [2021B0101420005]; Aiyou Foundation [KY201701]

作者

  • W

    Wang, Xin (第一作者)

    chinese acad med sci · peking union med coll

  • X

    Xu, Zhenyi

    harbin med univ

查看全部 8 位作者收起作者
  • L

    Liu, Zhilin

    peking univ

  • L

    Lin, Weihao

    chinese acad med sci · peking union med coll

  • C

    Cao, Zheng

    chinese acad med sci · peking union med coll

  • F

    Feng, Xiaoli

    chinese acad med sci · peking union med coll

  • G

    Gao, Yibo (通讯)

    chinese acad med sci · peking union med coll

  • H

    He, Jie (通讯)

    chinese acad med sci · peking union med coll

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417